Seres Therapeutics
Earnings Surprise
Analysts estimated MCRB earnings of $-2.15 per share this quarter (Q4). MCRB's actual earnings were $-1.78 per share.
MCRB EPS surprise of 17.29%Analysts estimated MCRB earnings of $1.31 per share this quarter (Q3). MCRB's actual earnings were $0.94 per share.
MCRB EPS surprise of 38.89%Analysts estimated MCRB earnings of $-2.54 per share this quarter (Q2). MCRB's actual earnings were $-2.27 per share.
MCRB EPS surprise of 10.71%Analysts estimated MCRB earnings of $-0.55 per share this quarter (Q1). MCRB's actual earnings were $-2.96 per share.
MCRB EPS surprise of -437.40%Analysts estimated MCRB earnings of $-0.20 per share this quarter (Q4). MCRB's actual earnings were $-0.10 per share.
MCRB EPS surprise of 50.20%Analysts estimated MCRB earnings of $-0.25 per share this quarter (Q3). MCRB's actual earnings were $-0.38 per share.
MCRB EPS surprise of -51.82%Analysts estimated MCRB earnings of $-0.28 per share this quarter (Q2). MCRB's actual earnings were $-0.22 per share.
MCRB EPS surprise of 21.29%Analysts estimated MCRB earnings of $-0.35 per share this quarter (Q1). MCRB's actual earnings were $-0.27 per share.
MCRB EPS surprise of 22.32%Analysts estimated MCRB earnings of $-0.51 per share this quarter (Q4). MCRB's actual earnings were $-0.32 per share.
MCRB EPS surprise of -36.90%